IPO registrations (S-1, F-1) · Registrants

NephroGenex, Inc.

SEC CIK
1338095 · filings on EDGAR ↗
Former names
NephroGenex Inc (2005–2008)
Registration
Form S-1, first filed 2013-12-23, last 2015-07-16; 2 initial registrations, 9 amendments
Outcome
Final prospectus filed 2014-02-12; declared effective 2014-02-10
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
P.O. BOX 400, Jamison, PA 18929
EDGAR entity type
operating
Insiders and CEO pay
NephroGenex, Inc. on the corporate pages

Offering terms

Proposed price range
$12.00–$14.00 per share (S-1/A filed 2014-02-03)
Final price
$12.00 per share, within the range (424B4 filed 2014-02-12, an initial public offering)
Shares sold
3,100,000
Gross proceeds
$37,200,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol NRX
Lead underwriters
Aegis Capital

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 18

FiledFormWhat it isName as filedEDGAR
2013-12-23S-1S-1 (registration)NephroGenex, Inc.0001571049-13-001292 ↗
2014-01-10S-1/AS-1/A (amendment)NephroGenex, Inc.0001571049-14-000082 ↗
2014-01-17S-1/AS-1/A (amendment)NephroGenex, Inc.0001571049-14-000131 ↗
2014-01-29S-1/AS-1/A (amendment)NephroGenex, Inc.0001571049-14-000268 ↗
2014-02-03S-1/AS-1/A (amendment)NephroGenex, Inc.0001571049-14-000299 ↗
2014-02-10EFFECTEFFECT (declared effective)NephroGenex, Inc.9999999995-14-000380 ↗
2014-02-12424B4424B4 (final prospectus)NephroGenex, Inc.0001571049-14-000390 ↗
2015-04-20S-1S-1 (registration)NephroGenex, Inc.0001047469-15-003696 ↗
2015-04-30S-1/AS-1/A (amendment)NephroGenex, Inc.0001047469-15-004216 ↗
2015-06-25S-1/AS-1/A (amendment)NephroGenex, Inc.0001047469-15-005756 ↗
2015-07-07S-1/AS-1/A (amendment)NephroGenex, Inc.0001047469-15-005980 ↗
2015-07-07S-1/AS-1/A (amendment)NephroGenex, Inc.0001047469-15-005989 ↗
2015-07-16S-1/AS-1/A (amendment)NephroGenex, Inc.0001047469-15-006150 ↗
2015-07-16S-1MEFS-1MEF (added securities)NephroGenex, Inc.0001104659-15-051525 ↗
2015-07-16EFFECTEFFECT (declared effective)NephroGenex, Inc.9999999995-15-001945 ↗
2015-08-21EFFECTEFFECT (declared effective)NephroGenex, Inc.9999999995-15-002359 ↗
2015-12-11EFFECTEFFECT (declared effective)NephroGenex, Inc.9999999995-15-003253 ↗
2015-12-15EFFECTEFFECT (declared effective)NephroGenex, Inc.9999999995-15-003295 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2014-02-03S-1/Aregistration statement$12.00–$14.003,100,000-Nasdaq NRX1primary document; range, shares headline, cover names 1document ↗
2014-02-12424B4final prospectus$12.003,100,000$37,200,000Nasdaq NRX1primary document; price sentence, shares headline, proceeds table, cover names 1document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Care Capital III LLCDirector,TenPercentOwner22014
Care Capital Investments III L.P.Director,TenPercentOwner22014
Care Capital Offshore Investments III LPDirector,TenPercentOwner22014
Fox J. WesleyDirector,Officer; OfficerPres. & Chief Sci. Officer62014–2015
Hamill JohnOfficerChief Financial Officer62014–2015
KAIROUZ HABIBDirector,TenPercentOwner; TenPercentOwner32014–2015
Legault PierreDirector,OfficerChief Executive Officer52014–2015
LESCHLY MARKDirector,TenPercentOwner; TenPercentOwner32014–2015
Markham Richard JDirector; Director,TenPercentOwner42014–2015
Peterson BobOfficerVP of Prod. Dev. & Reg Aff's.; VP of Prod. Dev. & Reg. Aff's.62014–2015
Rho Capital Partners LLCDirector,TenPercentOwner; TenPercentOwner32014–2015
Rho Ventures V Affiliates, LLCDirector,TenPercentOwner; TenPercentOwner32014–2015
Rho Ventures V, L.P.Director,TenPercentOwner; TenPercentOwner32014–2015
RMV V, L.L.C.Director,TenPercentOwner; TenPercentOwner32014–2015
RUCH JOSHUADirector,TenPercentOwner; TenPercentOwner32014–2015
Seltzer Robert R.Director; Director,TenPercentOwner42014–2015
Steiner EugenDirector42014–2015
VOGELBAUM MARTINDirector32014
Mitchum James P.Director32014–2015
Taglietti MarcoDirector32014–2015
Patel JaikrishnaOfficerChief Medical Officer32015

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2015-11-13NephroGenex, Inc.Pharmaceuticals$28,500,000$5,500,000141

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Form D issuerNephroGenex, Inc.NCForm D private offeringsCIK (EXACT)
SEC filerNephroGenex, Inc.SEC filers (EDGAR)CIK (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, PA first:

More with this interest.

In other datasets, the same topic (Health) in PA:

Interests: Pharmaceutical Preparations · Health